## Diagnostic Confirmation of Rheumatoid Arthritis ### Why Anti-CCP Antibody is Most Specific **Key Point:** Anti-CCP (anti-cyclic citrullinated peptide) antibody is the most specific serological marker for rheumatoid arthritis, with specificity >95% and sensitivity ~70%. It is superior to rheumatoid factor for confirming the diagnosis and predicting disease progression and erosive joint damage. **High-Yield:** Anti-CCP antibodies are: - Present in ~70% of RA patients (compared to RF positivity in ~80%) - Highly specific for RA (>95% specificity vs. ~85% for RF) - Predictive of poor prognosis and erosive disease even when RF is negative - Detectable years before symptom onset (prognostic value) - The preferred confirmatory test in 2021 ACR/EULAR RA classification criteria ### Serological Markers in Rheumatoid Arthritis | Marker | Sensitivity | Specificity | Clinical Use | |--------|-------------|-------------|---------------| | Rheumatoid Factor (RF) | ~80% | ~85% | Supports diagnosis; less specific | | Anti-CCP antibody | ~70% | >95% | **Gold standard for confirmation** | | ANA | ~40% | Low | Non-specific; may overlap with other CTD | | Anti-dsDNA | Rare in RA | High | Suggests SLE, not RA | **Mnemonic:** **ANTI-CCP = Confirmatory, Predictive, Pathogenic** - **C**onfirmatory: most specific for RA diagnosis - **P**redictive: predicts erosive disease and poor prognosis - **P**athogenic: directly involved in joint inflammation (citrullination of joint proteins) **Clinical Pearl:** A patient with positive anti-CCP but negative RF still has RA and should be treated aggressively, as anti-CCP seropositivity alone predicts erosive disease. ### Why Other Investigations Are Not Most Specific **Warning:** ESR and CRP are markers of inflammation, not disease-specific. They reflect disease activity but cannot confirm the diagnosis; many other conditions elevate these markers.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.